Orion Corporation (Finnish company)
Native name | Orion Oyj |
|---|---|
| Company type | Julkinen osakeyhtiö |
| Nasdaq Helsinki: ORNAV, ORNBV | |
| Industry | Pharmaceutical industry |
| Founded | 21 September 1917 |
| Headquarters | Espoo, Finland |
Key people | Liisa Hurme (President and CEO), Mikael Silvennoinen (Chairman) |
| Products | Pharmaceuticals and active pharmaceutical ingredients |
| Revenue | €1.041 billion (2021) |
| €243.3 million (2021) | |
| €193.8 million (2021) | |
| Total assets | €1.114 billion (2021) |
| Total equity | €747.9 million (2021) |
Number of employees | 3,364 (2021) |
| Website | www |
| Footnotes / references | |
Orion Corporation (Finnish: Orion Oyj), founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.
Orion's class A and B shares are listed on the Helsinki Stock Exchange.